Treatment Options for OCD: An Evidence-Based Guide for Indian Families
Modern OCD treatment rests on two evidence-based pillars – Exposure and Response Prevention (ERP) and SSRI medication – and most people who get the right combination see meaningful, lasting improvement.
Senior Consultant Psychiatrist, Abhasa Rehab and Wellness
- Last Updated: 2026-06-26
- Published: 2026-06-26
- 12 min read
Key Takeaways
- Two evidence-based pillars treat OCD - psychotherapy (especially Exposure and Response Prevention, ERP) and medication (especially SSRIs).
- ERP is first-line with response rates of 60–75% and large effect sizes (Cohen's d 1.31–1.59) across trials [1].
- SSRIs help 40–60% of people respond meaningfully OCD typically needs higher doses and longer trials than depression does [4][5].
- Combination of ERP plus medication can push response rates to 70–85% in moderate-to-severe presentations [2] .
- Treatment-resistant OCD has options augmentation, intensive programmes, and procedural treatments and decisions belong with a psychiatric team.
- About half of people with OCD have a co-occurring condition (depression, anxiety, or substance use), and treatment plans should account for both [9] .
- Overview
- Symptoms
- Treatment
- Recovery
You have probably already read about what OCD is. Maybe you have read about the types of OCD. Now you are looking for the next sensible question what actually treats it? This is the right question. And there are clear answers.
Forty years of carefully designed research, large meta-analyses, and clinical guidelines from the World Health Organization, the American Psychiatric Association, and India’s own National Mental Health Survey converge on a small handful of treatments that work.
Most people with OCD get meaningfully better. Many reach long stretches of remission. The treatment delay in OCD is often 14 to 17 years between symptom onset and first effective help [13] and most of that delay is information, not unwillingness. This page is here to shorten that gap for you.
What does “OCD treatment” mean today? Modern OCD treatment combines two evidence-based pillars a structured form of psychotherapy called Exposure and Response Prevention (ERP), and a class of medications called serotonin reuptake inhibitors (SSRIs).
Either pillar alone helps most people. Together, for moderate-to-severe OCD, they help even more. Newer options exist for cases that need more augmentation strategies, intensive outpatient programmes, residential care, and, in selected cases, brain-stimulation procedures.
This guide walks you through the full picture so you can have an informed conversation with your psychiatrist.
Who This Guide Is For
This guide is written for:
- Adults with OCD trying to understand what their treatment options actually are, before walking into a clinic.
- Family members supporting a loved one parents, partners, adult siblings who want a working map of the treatment landscape.
- General practitioners and counsellors in India who refer patients onward and want a concise summary of evidence-based pathways.
- Anyone in early recovery who wants to know what comes after the first appointment.
How OCD Is Treated Today - The Two-Pillar Framework
International clinical guidelines including the UK’s NICE Clinical Guideline CG31 and the American Psychiatric Association’s Practice Guideline for OCD agree on the core framework [3][5].
Indian psychiatry follows the same evidence base, with NIMHANS-led research feeding directly into how OCD is approached in tertiary centres across the country.
Two pillars hold up the framework.
QUICK ANSWER
OCD is treated with two evidence-based pillars a structured psychotherapy called Exposure and Response Prevention (ERP), and a medication class called selective serotonin reuptake inhibitors (SSRIs).
For mild-to-moderate OCD either pillar may be enough. For moderate-to-severe OCD, the two are often combined. Other psychotherapies, augmentation medications, and procedures are added when first-line treatment is insufficient
The dominant evidence-based psychotherapy for OCD is Exposure and Response Prevention (ERP), a specific form of Cognitive Behavioural Therapy (CBT). ERP works by helping you face the situations or thoughts that trigger obsessions, while gently holding back the compulsion that usually follows.
Over weeks, the brain learns that the feared outcome does not happen, that the discomfort passes on its own, and that the compulsion was never the safety mechanism it pretended to be.
Other psychotherapies, cognitive therapy (which focuses on thought patterns), Acceptance and Commitment Therapy (ACT, which is often blended with ERP for Pure-O presentations), and Mindfulness-Based CBT also have evidence, though usually as additions to ERP rather than substitutes for it.
For a deep dive into how ERP actually works, see our companion guide on ERP therapy for OCD.
The most widely studied medications for OCD are the SSRIs (fluoxetine, sertraline, fluvoxamine, paroxetine, escitalopram) and the older tricyclic clomipramine. These are not addictive, do not produce a “high,” and are not benzodiazepines.
They typically take 8 to 12 weeks at an adequate dose before their full effect on OCD shows up slower than they work for depression, and at higher doses.
If first-line medication only partly works, psychiatrists may add an augmentation agent (such as a low-dose atypical antipsychotic) or switch to clomipramine. Treatment plans are individual.
For the full medication picture typical dose ranges, side-effect monitoring, augmentation, and what to ask your psychiatrist see our deep-dive on medications for OCD.
For moderate-to-severe OCD, combination treatment (ERP plus medication) is often the most effective path.
The Foa 2005 trial the largest randomised study in this area found that combination therapy outperformed either treatment alone, with response rates in the 70–85% range when both were delivered well [2].
Most guidelines now recommend offering combination treatment to anyone with moderate-to-severe OCD or with significant co-occurring depression.
First-Line Treatment - Exposure and Response Prevention (ERP)
QUICK ANSWER
ERP is the most strongly evidence-based psychotherapy for OCD. In a typical course of 12 to 20 sessions, a trained therapist helps you face triggers in a planned, graded way and gently resist the compulsions that usually follow.
Across pooled studies, 60–75% of people show a meaningful response, with effect sizes (Cohen’s d 1.31–1.59) that are among the largest in psychotherapy research [1].
Two things make ERP unusual.
The first is that it is active. You and your therapist build a list of triggering situations or thoughts ranked by how distressing each one is.
You then work up that list together, exposing yourself in real life, washing one fewer time, leaving the gas knob unchecked, holding the intrusive thought without trying to neutralise it. The therapist coaches you do the work.
The second is that it is learning-based. The newer “inhibitory learning” model of ERP describes what happens in the brain during exposure a new memory is laid down I sat with this discomfort and nothing terrible happened, which gradually competes with the older OCD memory. Over weeks, the new learning wins more often. The compulsion stops feeling necessary.
ERP is adapted slightly for each OCD subtype for example, imaginal exposure scripts for Harm OCD, in-vivo washing exposures for Contamination OCD, and an ACT-blended approach for Pure O where compulsions are mostly mental. You can read more on subtype-specific ERP in our ERP therapy guide.
Medication Options for OCD
QUICK ANSWER
The first-line medications for OCD are SSRIs (fluoxetine, sertraline, fluvoxamine, paroxetine, escitalopram), with response rates of about 40–60% [4].
Clomipramine, an older tricyclic, is the main second-line option with slightly higher response rates but more side effects [7]. OCD doses are typically higher than depression doses, and an adequate trial usually means 10–12 weeks at the target dose [3].
Most psychiatrists will start with an SSRI. Which SSRI depends on your other medications, side-effect history, co-occurring conditions, and how you have responded to anything in the same family before. Two important things often catch families off guard
- OCD takes longer to respond to medication than depression does. Many people feel little change for the first 6 to 8 weeks. This is normal. NICE CG31 explicitly recommends a full 10–12 week trial at an adequate dose before judging whether an SSRI is working [3].
- OCD doses are typically higher than depression doses. The APA Practice Guideline for OCD documents this dose-response pattern across SSRIs [5]. Your psychiatrist will titrate the dose upward in steps, watching for side effects, until you are at a dose with a reasonable chance of helping OCD specifically.
For typical dose ranges, side-effect monitoring, and what augmentation looks like, see our full guide on medications for OCD.
Combination Treatment - When ERP and Medication Together
For moderate-to-severe OCD, the strongest evidence supports combining ERP and an SSRI from the start. The landmark Foa 2005 trial randomised participants with OCD to ERP alone, clomipramine alone, the combination, or pill placebo.
Combination treatment was the most effective arm, with response rates in the 70–85% range meaningfully better than either treatment alone [2].
Combination tends to be the right starting point when:
- OCD is moderate to severe (Y-BOCS score around 24 or higher)
- You also have depression that is interfering with daily life
- You have tried one of the two pillars without enough benefit
- You are starting from a long delay in seeking treatment and want momentum quickly
If you are already in treatment with one pillar and wondering whether to add the other, that is a conversation to have with your treating psychiatrist or psychologist. For severe or treatment-resistant OCD, see our spoke on severe OCD treatment.
Beyond First-Line - Treatment-Resistant OCD
QUICK ANSWER
About 30–40% of people with OCD do not respond fully to a first SSRI plus ERP. For this group, evidence supports several next steps: trying a second SSRI, switching to clomipramine, augmenting with a low-dose atypical antipsychotic, intensifying psychotherapy with daily ERP sessions, or, in selected cases, considering procedural treatments like Transcranial Magnetic Stimulation (TMS) or Deep Brain Stimulation (DBS) [5][6].
- Optimise what you have already tried – increase the SSRI dose to the upper end of the OCD range, ensure ERP is being delivered with adequate exposure intensity, address sleep, exercise, and any untreated depression.
- Switch within the SSRI family – different SSRIs have different binding profiles non-response to one does not predict non-response to another.
- Switch to clomipramine – slightly higher response rates than SSRIs but more side effects, with cardiac monitoring required at higher doses.
- Augment – adding a low-dose atypical antipsychotic such as risperidone or aripiprazole has a small but real average effect in trials [6] glutamate modulators (memantine, NAC) have emerging but less mature evidence.
- Intensive ERP – daily or twice-daily sessions across 2–3 weeks, often in a residential or day-care setting.
- Procedural treatments – Transcranial Magnetic Stimulation (TMS) is now FDA-cleared for OCD in some jurisdictions Deep Brain Stimulation (DBS) is reserved for very severe, treatment-resistant cases evaluated by specialised teams. These are not first-line and are considered only after multiple adequate trials of first-line treatment.
Decisions about treatment-resistant OCD belong with a psychiatric team that knows your full history. For the deeper picture, see our spoke on severe OCD treatment.
Treating OCD With Co-Occurring Conditions
- OCD with depression depression often responds first OCD responds more slowly. The same SSRI usually treats both, though sometimes at different doses. ERP can be harder to engage with when depression is severe, so addressing depression first sometimes makes sense. See OCD and depression.
- OCD with anxiety disorders generalised anxiety, panic, or social anxiety often co-occur. SSRIs treat all of these, and ERP techniques transfer to anxiety work. See OCD and anxiety.
- OCD with substance use alcohol, cannabis, or prescription-medication misuse can mask or worsen OCD. Treating both at the same time is usually necessary. See OCD and substance use and Abhasa’s Dual Diagnosis Rehab.
If you recognise a pattern in any of these, please do tell the assessing clinician. Co-occurring conditions are the rule, not the exception.
Where Treatment Happens - Outpatient, Day-Care, Residential
OCD treatment can be delivered in different settings, and where you are treated should match how much support you need.
- Outpatient ERP and medication management the standard pathway. You see a psychologist or psychiatrist weekly (more often initially), continue your work and family life, and do the bulk of ERP between sessions.
- Intensive outpatient or day-care programmes daily or near-daily ERP across 2–3 weeks, used when symptoms are severe, when weekly outpatient ERP has not been enough, or when you need protected time to focus on recovery.
- Residential treatment inpatient stays of several weeks to a few months, used when daily functioning is severely impaired, when there is significant co-occurring depression or substance use, or when home environment is reinforcing the OCD cycle. Residential settings allow daily ERP, full medication oversight, and a planned step-down back into outpatient care.
Choosing a Treatment Path - Five Practical Questions
At Abhasa Rehab and Wellness, OCD is treated through both outpatient and residential pathways, with care matched to the level of support needed. To learn more, see our OCD Treatment Centre page.
Families often ask us how to make the first decision. Here is the working frame most psychiatrists use, condensed into five questions you can sit with before your first appointment.
- How severe is the OCD right now? Mild OCD often responds to ERP alone. Moderate-to-severe usually benefits from combination treatment.
- Is there a co-occurring condition? Depression, anxiety, ADHD, or substance use shapes which medication and which therapy approach makes sense first.
- What has been tried already, and for how long? A “failed” SSRI trial that lasted only 3 weeks at low dose is not the same thing as a true treatment failure. Honest history matters.
- What support is available at home? ERP works best when home is not constantly reinforcing rituals. Family-supported ERP can change the trajectory.
- What does the next 6–12 months realistically look like? Treatment is a project, not a quick fix. Building it around the person’s work, school, and life context makes adherence possible.
These are conversations to have with the assessing psychiatrist and psychologist. There is no single right answer there is a right-for-you answer.
How Abhasa Approaches OCD Treatment
At Abhasa Rehab and Wellness, OCD treatment is delivered by a multidisciplinary team of psychiatrists, clinical psychologists, residential medical staff, and family counsellors working together rather than in silos.
Across our residential and outpatient programmes, the published recovery rate sits at 75% (defined as sustained symptom remission and return to functioning at six-month follow-up), supported by a 2:1 staff-to-resident ratio that allows daily ERP intensity when it is needed.
Clinical leadership is provided by Dr. Naveen Kumar (MBBS, DPM, Consulting Psychiatrist with 20+ years of experience in addiction psychiatry and dual diagnosis), with clinical psychology guidance from Ms. Meera K (M.Phil Clinical Psychology) and additional psychiatric consultation from Dr. Shree Aarthi (MBBS, MD, DNB).
To begin a confidential assessment, see our Admission Guide or visit the OCD Treatment Centre page.
Frequently asked questions
OCD is not “cured” the way an infection is cured. It is treated. With evidence-based ERP and/or SSRI medication, most people reach long stretches of remission with minimal symptoms often for years at a time.
A smaller number of people experience occasional flare-ups during major life stress, which usually respond quickly to a brief return to ERP or a temporary medication adjustment. The realistic goal is durable remission, not zero thoughts forever.
The best evidence supports Exposure and Response Prevention (ERP) as the first-line psychotherapy and SSRIs as the first-line medication [3][5].
For mild OCD, ERP alone is often enough. For moderate-to-severe OCD, the combination of ERP and SSRI is more effective than either alone [2].
The “best treatment” for you depends on severity, co-occurring conditions, prior treatment history, and personal preference discussed with a psychiatrist.
A standard course of ERP runs 12 to 20 weekly sessions [3]. Most people notice meaningful improvement within the first 6 to 8 sessions if exposures are being done with adequate intensity between sessions. Severe or complex cases may take longer or benefit from intensive (daily) formats.
No. The first-line medications for OCD, SSRIs and clomipramine, are not addictive and do not produce a “high.” They are not benzodiazepines (a different class sometimes used short-term for severe anxiety, which can be dependence-forming).
SSRIs do, however, need to be tapered slowly when stopped, because abrupt discontinuation can cause temporary discontinuation symptoms. This is different from addiction.
Some Ayurvedic herbs (Ashwagandha, Brahmi, Jatamansi) are widely used in India for stress and mood support, and there are early studies suggesting Ashwagandha may help reduce OCD symptom severity when added to standard SSRI treatment.
However, no Ayurvedic preparation has the strength of evidence behind it that ERP and SSRIs do, and herbs can interact with prescription medications. If you want to use an Ayurvedic preparation, please discuss it with your psychiatrist first so they can monitor for interactions.
To speak with our clinical team about an assessment
Call +91 73736 44444 or WhatsApp the same number. For our dedicated OCD Treatment Centre page, click here.
Closing - There Is a Way Forward
OCD has been one of the most carefully studied conditions in modern psychiatry. The treatments that work, work well. ERP changes the brain’s relationship to obsessions. SSRIs reduce their grip.
Combination treatment, augmentation, and intensive programmes catch the cases first-line work doesn’t. Co-occurring depression, anxiety, and substance use have their own paths, often handled in the same plan.
If you are unsure where to start, the most useful first step is a confidential psychiatric assessment with a clinician who treats OCD regularly. Bring an honest history. Bring the questions in this guide. Ask what they think the right starting framework is for you and why.
For more, see our Types of OCD
References
[1] Öst LG, et al. Cognitive behavior therapy for obsessive-compulsive disorder in adults: A systematic review and meta-analysis of individual patient data. Depress Anxiety. 2015;32(4):239-251.
https://www.sciencedirect.com/science/article/abs/pii/S221136491830054X
[2] Foa EB, et al. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry. 2005;162(1):151-161.
https://pubmed.ncbi.nlm.nih.gov/15625214/
[3] American Psychiatric Association. Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder. 2007.
https://pubmed.ncbi.nlm.nih.gov/17849776/
[4] Wilhelm S, et al. Cognitive therapy for obsessive-compulsive disorder: A meta-analysis. Behav Ther. 2009;40(1):55-67. PMC2724959.
https://www.sciencedirect.com/science/article/abs/pii/S1077722908001119
[5] Soomro GM, et al. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev. 2008;1:CD001765.
https://pubmed.ncbi.nlm.nih.gov/18253995/
[6] World Health Organization / DSM-5-TR. OCD prevalence (2-3% globally).
https://www.ncbi.nlm.nih.gov/books/NBK553162/
[7] Doron G, Derby DS, et al. Relationship-focused obsessive-compulsive symptoms: typology and clinical features.
https://www.sciencedirect.com/science/article/abs/pii/S2211364913000924
[8] Doron G, et al. Prevalence and correlates of relationship-related obsessive-compulsive phenomena.
https://pubmed.ncbi.nlm.nih.gov/27148087/
[9] American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, Text Revision (DSM-5-TR). 2022. OCD spectrum classification.
https://www.psychiatry.org/psychiatrists/practice/dsm
- Reviewed by
- Senior Consultant Psychiatrist
- Abhasa Rehab and Wellness
Medical Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional for personalised medical guidance. If you or someone you know is in crisis, please contact emergency services (112) or one of the helplines listed above
If you or someone you know is in immediate danger:
Emergency Helplines:
- Vandrevala Foundation: 1860-2662-345 (24/7 Mental Health Crisis)
- iCall: 9152987821 (Mon-Sat, 8am-10pm)
- NIMHANS Helpline: 080-46110007 (Psychiatric Emergency)
- National Mental Health Helpline (India): 1800-599-0019 (Toll-free)
Abhasa 24/7 Helpline: +91-73736-44444
Emergency: If experiencing a medical emergency, call 112 or visit your nearest emergency room.